Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMetabolic Biomarkers in Thoracic Cancers
- Where
- Dallas
- Age
- 18 years and over
- People
- 200
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT02095808 - No phaseTaking peopleTumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- Where
- Columbia
- Age
- 18 years and over
- People
- 620
- Run by
- University of Missouri-Columbia
See details and how to joinNCT02838836 - No phaseTaking peopleComparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Where
- Birmingham, Duarte, Fresno, Fruitdale, Fullerton, Honolulu, Las Vegas, Los Angeles, Mather, Mobile, Monterey, Palo Alto, Salt Lake City, San Francisco
- Age
- 18 years and over
- People
- 2,996
- Run by
- Stanford University
See details and how to joinNCT05297734 - Phase 2Taking peopleATATcH Alternating Treatment Plans for Advanced Cancer
- Where
- Elizabeth, Hamilton, Jersey City, Lakewood, Livingston, Long Branch, Newark, New Brunswick, Somerville, Toms River
- Age
- 18 years and over
- People
- 150
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT05358548 - No phaseTaking peoplePromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
- Where
- Miami
- Age
- 18 years to 80 years
- People
- 44
- Run by
- University of Miami
See details and how to joinNCT06124508 - No phaseTaking peopleMolecular Predictors of Cancer in Patients at High Risk of Lung Cancer
- Where
- Nashville
- Age
- 18 years and over
- People
- 4,000
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT00898313 - Phase 1/2Taking peopleA First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer
- Where
- Ohio City
- Age
- 19 years and over
- People
- 140
- Run by
- Chong Kun Dang Pharmaceutical
See details and how to joinNCT07439094 - No phaseTaking peopleRural Illinois Lung Cancer Screening Initiative
- Where
- Springfield
- Age
- 50 years to 80 years
- People
- 10,000
- Run by
- Southern Illinois University
See details and how to joinNCT06084078 - Phase 1/2Taking peopleA Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Where
- Fairfax, Houston, San Antonio
- Age
- 18 years to 75 years
- People
- 440 worldwide
- Run by
- Tyligand Pharmaceuticals (Suzhou) Limited
See details and how to joinNCT06385925 - Phase 2Taking peopleSafety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
- Where
- Birmingham, Elizabethtown, Houston, New York, Tampa
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06841055 · EU 2024-518279-80-00 - Phase 2/3Taking peopleA Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
- Where
- Chicago, Cleveland, Duarte, Miami
- Age
- 18 years to 100 years
- People
- 40
- Run by
- Privo Technologies
See details and how to joinNCT05893888 - No phaseTaking peopleMultiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
- Where
- Dallas
- Age
- 18 years to 99 years
- People
- 2,000
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT03563976 - Phase 2Taking peoplePreoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
- Where
- New York
- Age
- 18 years and over
- People
- 112
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT06623656 - No phaseTaking peopleThe Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
- Where
- Tucson
- Age
- 18 years and over
- People
- 48
- Run by
- University of Arizona
See details and how to joinNCT07216209 - No phaseTaking peoplePatient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
- Where
- San Antonio
- Age
- 18 years and over
- People
- 150
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT03655015 - Phase 2Taking peopleTelisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 60
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT07323641 - Phase 1/2Taking peopleA Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 53
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07535463 - Phase 3Taking peopleJoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Where
- Annapolis, Aurora, Austin, Baltimore, Boca Raton, Boston, Chapel Hill, Charlottesville, Cincinnati, Cleveland, Colorado Springs, Columbus, Dallas, Detroit, Falls Church, Iowa City, Kansas City, La Jolla, Lexington, Louisville, Memphis, Milwaukee, Neptune City, New Orleans, New York, Philadelphia, Pittsburgh, Portland, Providence, Rochester, Royal Oak, Salt Lake City, Savannah, Seattle, State College, Syracuse, Winston-Salem
- Age
- 18 years and over
- People
- 272 worldwide
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT02468024 - Phase 2Taking peopleTATE and Pembrolizumab (MK3475) in mCRC and NSCLC
- Where
- Orange
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- Teclison Ltd.
See details and how to joinNCT04701476 - Phase 2Taking peoplePatient Preference for Subcutaneous vs. Intravenous Immune Therapy
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 880
- Run by
- Diwakar Davar
See details and how to joinNCT07223424 - No phaseTaking peopleIncentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
- Where
- Camden
- Age
- 18 years and over
- People
- 100
- Run by
- Cooper Norcross Health
See details and how to joinNCT06688422 - Phase 1Taking peoplePhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
- Where
- Baltimore, Buffalo, Detroit, Duarte, Fairfax, Houston, Newport Beach, New York, Orange, Santa Rosa, Tacoma, The Bronx, Westwood
- Age
- 18 years and over
- People
- 304 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00 - No phaseTaking peoplePatient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 40
- Run by
- The New York Proton Center
See details and how to joinNCT06342284 - Phase 1/2Taking peopleA Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Where
- Aurora, Houston, Lake Mary, Lebanon, Providence
- Age
- 18 years and over
- People
- 126
- Run by
- 7 Hills Pharma, LLC
See details and how to joinNCT06362369 - Phase 2Taking peopleThoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
- Where
- The Bronx
- Age
- 18 years and over
- People
- 76
- Run by
- Montefiore Medical Center
See details and how to joinNCT06865339